J Food Prot 2008, 71:93–101 PubMed Authors’ contributions PR

J Food Prot 2008, 71:93–101.PubMed Authors’ contributions PR carried out the transcriptional analysis, help to perform the in vitro GI tract system and drafted the manuscript. AR and MF carried out the biogenic amines detection and quantification and performed the statistical analysis. PFP set up the in vitro GI tract, confocal https://www.selleckchem.com/screening/apoptosis-library.html microscope analysis and the adhesion assay experiments. GS, PL and PaLu participated in the design of the

study, coordination and helped to draft the manuscript. All authors read and approved the final manuscript.”
“Background B lymphocytes, in addition to their role as precursors of antibody producer cells (plasma cells), are responsible for the production of cytokines such as Interleukin (IL)-4, IL-6, IL-10, and tumour necrosis factor-alpha (TNF-α) [1] and act as antigen-presenting cells; consequently, these cells CA3 are essential in the adaptive immune response. Most antigen-presenting cells, buy CX-5461 such as macrophages and dendritic cells, take up antigens in bulk to sense the extracellular environment. B lymphocytes, however, recognise specific antigens in soluble or membrane-bound forms through the B-cell receptor (BCR) [2]. Upon BCR interaction with the antigen, a cascade of signal transduction and second messengers is generated and the antigen is internalised

and subsequently processed for presentation through the major histocompatibility complex (MHC) II molecules for recognition by T cells [3]. The internalisation of the antigen in B cells occurs through at least two endocytic pathways: clathrin-mediated endocytosis and clathrin- and caveolin-independent endocytosis [3, 4]. However, B cells also express Ribonucleotide reductase a number of membrane receptors that initiate the innate immune response. These receptors include the Toll-like receptors (TLR) 1, 2 (low), 4 (low), and 6, 7, 9, and 10 [5]; low levels of DEC-205, which is a putative antigen uptake processing receptor [6]; the scavenger receptor Cluster of Differentiation 36 (CD36) [7]; and

the Dendritic Cell-Specific Intracellular adhesive molecule-3-Grabbing Nonintegrin (DC-SIGN) [8]. Of these, DC-SIGN is present only after B-cell activation by CD40L and Interleukin (IL)-4, which makes the B-cell able to internalise Human Herpes virus 8 (HHV 8) [8, 9]. In addition, CD36 enhances Toll-like receptor 2 (TLR2) signalling to induce cytokine production [7]. In contrast to the internalisation and procession of soluble antigen, the internalisation of particulate antigen by B cells has not been extensively investigated because, unlike “professional” phagocytes, B cells do not achieve phagocytosis [10]. However, recent evidence has shown that B cells can handle and process particle antigens, bacteria, and even protozoan parasites [10, 11]. It has been demonstrated that the particulate presentation of a BCR-recognised soluble antigen enhances the adaptive response by up to 105-fold [12].

Comments are closed.